Surrogate Markers and Risk Factors for Chronic Lung Allograft Dysfunction-Reference-Cited by-同舟云学术

Surrogate Markers and Risk Factors for Chronic Lung Allograft Dysfunction

Published:2004-07 Issue:7 Volume:4 Page:1171-1178
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Bowdish Michael E.,Arcasoy Selim M.,Wilt Jessie S.,Conte John V.,Davis Robert Duane,Garrity Edward R.,Hertz Marshall L.,Orens Jonathan B.,Rosengard Bruce R.,Barr Mark L.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2004.00483.x/fullpdf

Reference115 articles.

1. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease

2. The registry of the international society for heart and lung transplantation: twentieth official adult lung and heart–lung transplant report—2003

3. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation

4. Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation

5. Chronic rejection following lung transplantation *1Incidence, time pattern and consequences

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of Transbronchial Cryobiopsy in Lung Transplant Recipients;The Annals of Thoracic Surgery;2019-10

2. Lung Transplantation for Idiopathic Pulmonary Fibrosis;Respiratory Medicine;2018-12-15

3. High circulating CD4 + CD25 hi FOXP3 + T-cell sub-population early after lung transplantation is associated with development of bronchiolitis obliterans syndrome;The Journal of Heart and Lung Transplantation;2018-06

4. Spezifische Infektionen bei Organtransplantationen;Der Internist;2016-01

5. Lung Transplantation for Idiopathic Pulmonary Fibrosis;Idiopathic Pulmonary Fibrosis;2013-09-13